[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Trever G. Bivona<\/i><\/u><\/presenter>. UCSF - University of California San Francisco, San Francisco, CA","CSlideId":"","ControlKey":"a806e9f5-8127-4365-8606-f7f74262606a","ControlNumber":"324","DisclosureBlock":"&nbsp;<b>T.G. Bivona:<\/b> None.","End":"4\/9\/2022 10:01:00 AM","HasWebcast":null,"Highlights":[],"Id":"179","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Trever Bivona, MD;PhD","PresenterKey":"b681040b-14ac-4894-857f-d2b4f24e0896","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"133","SessionOnDemand":"False","SessionTitle":"Advances in SHP2 Biology and Therapeutics for Targeting RAS-Driven Cancers","ShowChatLink":"false","Start":"4\/9\/2022 10:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Trever G. Bivona<\/i><\/u><\/presenter>. UCSF - University of California San Francisco, San Francisco, CA","CSlideId":"","ControlKey":"416e36e4-8b77-42c9-bd69-ead0478ba326","ControlNumber":"7052","DisclosureBlock":"","End":"4\/9\/2022 10:20:00 AM","HasWebcast":null,"Highlights":[],"Id":"695","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Trever Bivona, MD;PhD","PresenterKey":"b681040b-14ac-4894-857f-d2b4f24e0896","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Molecular modifiers of SHP2 inhibitor sensitivity","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"133","SessionOnDemand":"False","SessionTitle":"Advances in SHP2 Biology and Therapeutics for Targeting RAS-Driven Cancers","ShowChatLink":"false","Start":"4\/9\/2022 10:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Molecular modifiers of SHP2 inhibitor sensitivity","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"0ce4569d-3c3e-4a67-962e-c504dac0b41c","ControlNumber":"7391","DisclosureBlock":"","End":"4\/9\/2022 10:30:00 AM","HasWebcast":null,"Highlights":[],"Id":"6154","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"133","SessionOnDemand":"False","SessionTitle":"Advances in SHP2 Biology and Therapeutics for Targeting RAS-Driven Cancers","ShowChatLink":"false","Start":"4\/9\/2022 10:20:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>René Bernards<\/i><\/u><\/presenter>. Netherlands Cancer Institute, Amsterdam, Netherlands","CSlideId":"","ControlKey":"7a88e68b-c42d-47fb-a551-2eaf14b825c4","ControlNumber":"7053","DisclosureBlock":"<b>&nbsp;R. Bernards, <\/b> <br><b>Agendia<\/b> Employment, Stock, No. <br><b>Oncosence<\/b> Stock, No. <br><b>Lixte<\/b> Grant\/Contract, No. <br><b>Heparegenix<\/b> Grant\/Contract, Yes.","End":"4\/9\/2022 10:50:00 AM","HasWebcast":null,"Highlights":[],"Id":"696","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"René Bernards, PhD","PresenterKey":"45bf3902-a13d-4642-b5a5-78df54b9d0c2","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"SHP2 inhibitor synthetic lethal drug combinations","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"133","SessionOnDemand":"False","SessionTitle":"Advances in SHP2 Biology and Therapeutics for Targeting RAS-Driven Cancers","ShowChatLink":"false","Start":"4\/9\/2022 10:30:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"SHP2 inhibitor synthetic lethal drug combinations","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"c42e7348-6ecb-4080-bed8-f79516c2cd1a","ControlNumber":"7392","DisclosureBlock":"","End":"4\/9\/2022 11:00:00 AM","HasWebcast":null,"Highlights":[],"Id":"6155","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"133","SessionOnDemand":"False","SessionTitle":"Advances in SHP2 Biology and Therapeutics for Targeting RAS-Driven Cancers","ShowChatLink":"false","Start":"4\/9\/2022 10:50:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Benjamin G. Neel<\/i><\/u><\/presenter>. Perlmutter Cancer Center at NYU Langone Health, New York, NY","CSlideId":"","ControlKey":"4ac17ae3-e63c-4866-9008-938688c1be67","ControlNumber":"7054","DisclosureBlock":"<b>&nbsp;B. G. Neel, <\/b> <br><b>Northern Biologics, Ltd<\/b> Stock, No. <br><b>Navire Pharma<\/b> Stock, Other, Consulting fees, Yes. <br><b>Jengu Therapeutics<\/b> Stock Option, No. <br><b>Arvinas, Inc<\/b> Stock Option, No. <br><b>Recursion Pharma<\/b> Stock Option, No. <br><b>Amgen, Inc<\/b> Stock, Other, wife held shares, we no longer hold them, Yes. <br><b>Regeneron<\/b> Stock, Other, Wife held shares--we no longer own them, No. <br><b>Moderna, Inc<\/b> Stock, Wife held shares; we no longer own them, No. <br><b>Repare Thx<\/b> Grant\/Contract, No. <br><b>Bridge Bio<\/b> Independent Contractor, Consultant, No. <br><b>Halda, Inc<\/b> Independent Contractor, Other, Consultant.","End":"4\/9\/2022 11:20:00 AM","HasWebcast":null,"Highlights":[],"Id":"697","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":"","PresenterDisplayName":"Benjamin Neel, MD;PhD","PresenterKey":"f36614b2-dc65-43f4-ba4a-c118d5343c29","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Title to be announced","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"133","SessionOnDemand":"False","SessionTitle":"Advances in SHP2 Biology and Therapeutics for Targeting RAS-Driven Cancers","ShowChatLink":"false","Start":"4\/9\/2022 11:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Title to be announced","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"af6bcc5c-d38a-431a-bc57-8943641ea3f3","ControlNumber":"7393","DisclosureBlock":"","End":"4\/9\/2022 11:30:00 AM","HasWebcast":null,"Highlights":[],"Id":"6156","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"133","SessionOnDemand":"False","SessionTitle":"Advances in SHP2 Biology and Therapeutics for Targeting RAS-Driven Cancers","ShowChatLink":"false","Start":"4\/9\/2022 11:20:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""}]